Topiroxostat is a medication used to treat hyperuricemia, a condition caused by excess uric acid in the body. However, the drug is not completely pure and may contain impurities that can affect its effectiveness and safety. These impurities can include degradation products, residual solvents, and other byproducts of the manufacturing process. It is important to identify and control these impurities to ensure the quality and safety of the drug.
